Article
Axi-cel Shows Better Outcomes When Given After Corticosteroids in R/R LBCL
Rating:
0.0
Views:
84
Likes:
1
Library:
1
Administering corticosteroids prior to chimeric antigen receptor T-cell therapy with axicabtagene ciloleucel in adult patients with relapsed or refractory large B-cell lymphoma may positively impact the benefit/risk profile of axi-cel treatment.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value